Dmitry Babarykin earned his Biochemistry degree from the University of Latvia in 1973, followed by PhDs in Biochemistry (1980) and Physiology (1990). He has held roles at the Riga Medical Institute (now Riga Stradiņš University), University Clinical Hospital, and the Center of Transplantology, as well as an Associate Professor at the Faculty of Biology, University of Latvia. He is the Director and co-owner of Farma Balt Ltd. and the founder, CEO, and Chairman of the Board at the Institute of Innovative Biomedical Technology, Ltd. His research focuses on nutrition, digestion physiology, circulation physiology, mineral metabolism pathology, pharmacology, and biotechnology. He has published 209 scientific works, holds 9 patents, and is a member of several professional associations, including the Latvian Nephrology Association and the Biotechnology Society of Latvia. He also chairs the Latvian Food Supplement Manufacturers Association.
Dmitry Babarykin earned his Biochemistry degree from the University of Latvia in 1973, followed by PhDs in Biochemistry (1980) and Physiology (1990). He has held roles at the Riga Medical Institute (now Riga Stradiņš University), University Clinical Hospital, and the Center of Transplantology, as well as an Associate Professor at the Faculty of Biology, University of Latvia. He is the Director and co-owner of Farma Balt Ltd. and the founder, CEO, and Chairman of the Board at the Institute of Innovative Biomedical Technology, Ltd. His research focuses on nutrition, digestion physiology, circulation physiology, mineral metabolism pathology, pharmacology, and biotechnology. He has published 209 scientific works, holds 9 patents, and is a member of several professional associations, including the Latvian Nephrology Association and the Biotechnology Society of Latvia. He also chairs the Latvian Food Supplement Manufacturers Association.